Published in Diabetes on June 01, 1991
Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol (2003) 2.13
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A (1999) 1.68
Linkage disequilibrium among RFLPs at the insulin-receptor locus despite intervening Alu repeat sequences. Am J Hum Genet (1992) 1.09
Alternatively spliced variants of the insulin receptor protein. Expression in normal and diabetic human tissues. J Clin Invest (1992) 0.99
State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS). Int J Pediatr Endocrinol (2011) 0.90
Modulation of insulin receptor signalling: significance of altered receptor isoform patterns and mechanism of hyperglycaemia-induced receptor modulation. Diabetologia (1994) 0.86
Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: a population-based study. Am J Hum Genet (1996) 0.85
The Val985Met insulin-receptor variant in the Danish Caucasian population: lack of associations with non-insulin-dependent diabetes mellitus or insulin resistance. Am J Hum Genet (1997) 0.78
A variant insulin promoter in non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 0.78
The Ubiquitin Ligase CHIP Integrates Proteostasis and Aging by Regulation of Insulin Receptor Turnover. Cell (2017) 0.77
Pathophysiology of non-insulin-dependent diabetes and the search for candidate genes: dangerous liaisons? Acta Diabetol (1996) 0.76
Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene. Mol Genet Metab Rep (2014) 0.76
SNP analysis of follistatin gene associated with polycystic ovarian syndrome. Adv Appl Bioinform Chem (2010) 0.75
Association of genetic variants in INS (rs689), INSR (rs1799816) and PP1G.G (rs1799999) with type 2 diabetes (T2D): a case-control study in three ethnic groups from North-West India. Mol Genet Genomics (2015) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (2000) 10.66
Obesity and insulin resistance. J Clin Invest (2000) 10.47
Obesity and the regulation of energy balance. Cell (2001) 9.48
Role of leptin in the neuroendocrine response to fasting. Nature (1996) 8.02
Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature (1994) 7.86
Metformin. N Engl J Med (1996) 7.66
A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) (1972) 7.64
The new CCP4 Coordinate Library as a toolkit for the design of coordinate-related applications in protein crystallography. Acta Crystallogr D Biol Crystallogr (2004) 7.30
Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet (2000) 7.25
A transgenic model of visceral obesity and the metabolic syndrome. Science (2001) 6.22
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med (1995) 5.45
Adipogenesis and obesity: rounding out the big picture. Cell (1996) 5.15
The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med (1976) 5.09
Ongoing developments in CCP4 for high-throughput structure determination. Acta Crystallogr D Biol Crystallogr (2002) 4.99
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78
Leptin. Annu Rev Physiol (2000) 4.78
Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet (1989) 4.42
Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol (1998) 4.30
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
Adipose tissue as an endocrine organ. Trends Endocrinol Metab (2000) 4.07
Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell (1998) 3.84
C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ (1996) 3.61
Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med (1991) 3.58
Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest (2000) 3.50
Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science (1987) 3.44
Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (1998) 3.38
Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron (1999) 3.37
Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest (1995) 3.18
Direct demonstration that receptor crosslinking or aggregation is important in insulin action. Proc Natl Acad Sci U S A (1978) 3.15
Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res (1988) 3.10
Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med (1983) 3.07
The integration host factor of Escherichia coli binds to bent DNA at the origin of replication of the plasmid pSC101. Cell (1987) 3.06
Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem (1997) 3.01
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest (1996) 2.98
Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science (1975) 2.97
Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors. Arch Intern Med (1992) 2.95
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol (1998) 2.93
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med (1999) 2.75
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med (1997) 2.73
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest (1997) 2.73
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2007) 2.65
Linkage of type 2 diabetes to the glucokinase gene. Lancet (1992) 2.64
The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem (1999) 2.63
Differential methylation of hypoxanthine phosphoribosyltransferase genes on active and inactive human X chromosomes. Proc Natl Acad Sci U S A (1984) 2.52
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart (1997) 2.50
Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med (1997) 2.48
Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med (1988) 2.43
Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at -20 degrees C. Clin Chem (1992) 2.41
SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem (2000) 2.41
Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum (1999) 2.39
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev (1999) 2.37
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet (1973) 2.36
Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem (1995) 2.27
Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med (1979) 2.25
Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest (1998) 2.23
Home blood sampling for plasma glucose assay in control of diabetes. Br Med J (1978) 2.22
Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science (1999) 2.21
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med (1998) 2.20
Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group. Diabet Med (2000) 2.20
Fibrinogen: a link between chronic infection and coronary heart disease. Lancet (1994) 2.19
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15
Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images. Br J Radiol (2010) 2.12
Leptin regulation of neuroendocrine systems. Front Neuroendocrinol (2000) 2.12
Activation of PPARdelta alters lipid metabolism in db/db mice. FEBS Lett (2000) 2.10
Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes (1997) 2.10
Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci (1998) 2.08
Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism (1979) 2.07
Chemo-ablation of the prostate with dehydrated alcohol for the treatment of prostatic obstruction. J Urol (2002) 2.06
UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun (1997) 2.06
Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest (2001) 2.05
Severely impaired adipsin expression in genetic and acquired obesity. Science (1987) 2.03
Brown adipose tissue, beta 3-adrenergic receptors, and obesity. Annu Rev Med (1997) 2.03
British American Tobacco and the "insidious impact of illicit trade" in cigarettes across Africa. Tob Control (2008) 2.02
Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology (1996) 1.99
Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem (2000) 1.99
Leptin, nutrition, and reproduction: timing is everything. J Clin Endocrinol Metab (2000) 1.98
Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med (1999) 1.97
Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol (2003) 1.97
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97
Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci U S A (1986) 1.94
Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man. J Clin Invest (1987) 1.93
Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes (1990) 1.93
Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci U S A (1998) 1.92
Differential regulation of two glucose transporters in adipose cells from diabetic and insulin-treated diabetic rats. J Clin Invest (1989) 1.89
Hypoglycaemia in African children with severe malaria. Lancet (1987) 1.88
Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology (1999) 1.87
RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol Cell Biol (1995) 1.86
Detection of single-copy fetal DNA sequence from maternal blood. Lancet (1990) 1.85
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology (1998) 1.84
Characterization of the insulin resistance of aging. J Clin Invest (1983) 1.83
Can residents be trained to counsel patients about quitting smoking? Results from a randomized trial. J Gen Intern Med (1991) 1.81
Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology (1999) 1.81
The vesicle transport protein Vps33p is an ATP-binding protein that localizes to the cytosol in an energy-dependent manner. J Biol Chem (1998) 1.81